The responsibility for the sponsor determines that adequate and well-controlled studies showing the drug is safe and effective have been carried out, that information, coupled with information on the manufacturing procedures and controls used in producing the drug, is submitted to FDA in the form of
NDA. After comprehensive review by the FDA, the
NDA is either approved or not approved; upon approval, the drug may be marketed.